Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.
Authors
Evans, DWarwick, J
Astley, S
Stavrinos, P
Sahin, S
Ingham, S
McBurney, H
Eckersley, B
Harvie, M
Wilson, M
Beetles, U
Warren, R
Hufton, A
Sergeant, J
Newman, W
Buchan, I
Cuzick, J
Howell, Anthony
Affiliation
Genesis Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, UK.Issue Date
2012-07
Metadata
Show full item recordAbstract
The aim of this study is to determine breast cancer risk at mammographic screening episodes and integrate standard risk factors with mammographic density and genetic data to assess changing the screening interval based on risk and offer women at high risk preventive strategies. We report our experience of assessing breast cancer risk within the U.K. National Health Service Breast Screening Program using results from the first 10,000 women entered into the "Predicting Risk Of breast Cancer At Screening" study. Of the first 28,849 women attending for screening at fifteen sites in Manchester 10,000 (35%) consented to study entry and completed the questionnaire. The median 10-year Tyrer-Cuzick breast cancer risk was 2.65% (interquartile range, 2.10-3.45). A total of 107 women (1.07%) had 10-year risks 8% or higher (high breast cancer risk), with a further 8.20% having moderately increased risk (5%-8%). Mammographic density (percent dense area) was 60% or more in 8.3% of women. We collected saliva samples from 478 women for genetic analysis and will extend this to 18% of participants. At time of consent to the study, 95.0% of women indicated they wished to know their risk. Women with a 10-year risk of 8% or more or 5% to 8% and mammographic density of 60% or higher were invited to attend or be telephoned to receive risk counseling; 81.9% of those wishing to know their risk have received risk counseling and 85.7% of these were found to be eligible for a risk-reducing intervention. These results confirm the feasibility of determining breast cancer risk and acting on the information in the context of population-based mammographic screening.Citation
Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. 2012, 5 (7):943-51 Cancer Prev ResJournal
Cancer Prevention ResearchDOI
10.1158/1940-6207.CAPR-11-0458PubMed ID
22581816Type
ArticleLanguage
enISSN
1940-6215ae974a485f413a2113503eed53cd6c53
10.1158/1940-6207.CAPR-11-0458
Scopus Count
Collections
Related articles
- Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
- Authors: Brentnall AR, Cuzick J, Buist DSM, Bowles EJA
- Issue date: 2018 Sep 1
- Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
- Authors: Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, Buchan I, Donnelly LS, Howell A
- Issue date: 2014 Oct
- Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
- Authors: van Veen EM, Brentnall AR, Byers H, Harkness EF, Astley SM, Sampson S, Howell A, Newman WG, Cuzick J, Evans DGR
- Issue date: 2018 Apr 1
- A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
- Authors: Brentnall AR, van Veen EM, Harkness EF, Rafiq S, Byers H, Astley SM, Sampson S, Howell A, Newman WG, Cuzick J, Evans DGR
- Issue date: 2020 Apr 15
- Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
- Authors: Evans DGR, Harkness EF, Brentnall AR, van Veen EM, Astley SM, Byers H, Sampson S, Southworth J, Stavrinos P, Howell SJ, Maxwell AJ, Howell A, Newman WG, Cuzick J
- Issue date: 2019 Jul